InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Kling Douglas F. Officer active across 1 company, notably NewAmsterdam Pharma Co N.V.. In total, 10 reports have been recorded. Activity tracked since 26 March 2025. The latest transaction was filed on 15 July 2025 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Kling Douglas F is a declarant linked to NewAmsterdam Pharma Co N.V., where the listed role is Chief Operating Officer. He has 10 filings in total, and across the 10 sampled filings the most frequent transaction nature is option exercise, with a date range from 2025-01-07 to 2025-07-17.